Public Website Design for Biotech & Life Sciences
A clear public website —
not a validation of your science, and we won’t claim otherwise.
We design public-facing information and stakeholder-communication websites for biotech and life sciences organisations — company overview, pipeline or platform pages, and a clear contact path, built from content you supply and approve. This is not a regulatory-compliance service, a clinical trial or laboratory system, or scientific validation of any claim; those need separately-scoped work with qualified specialists, and we’ll say so plainly.
Prateeksha designs public-facing information and stakeholder-communication websites for biotech and life sciences organisations -- company overview, pipeline or platform pages, and contact information, built from content the client supplies and approves. This is not a regulatory-compliance service, a clinical trial or laboratory system, and not scientific validation of any claim; those require separately-scoped work with qualified specialists. Scientific findings, study claims, pipeline data, regulatory status, certifications, and investor materials must be client-supplied and approved.
What this service is
A public information and stakeholder-communication website: company overview, pipeline or platform pages, and a general enquiry form -- built from scientific findings, study claims, pipeline data, regulatory status, certifications, and investor materials that you supply and approve.
What this service is not
Not a regulatory-compliance service, not scientific or clinical validation, and not a clinical trial, laboratory, or protected research-data system. Those need separately-scoped work with qualified specialists -- we'll say so plainly if your situation needs one.
Where biotech websites go wrong
Most biotech and life sciences sites weren't built around how a stakeholder actually evaluates a company.
- 01
Science hard to follow
Technical or scientific language presented with no plain-language framing for a general stakeholder.
- 02
Pipeline or platform pages unclear
Program or platform information scattered or presented without a clear structure to follow.
- 03
Compliance overstated
Regulatory or compliance language used loosely, creating risk if it outpaces what is actually true.
- 04
Investor and partner content buried
Materials for investors, partners, or collaborators hard to find or inconsistently presented.
- 05
Contact path unclear
No clear indication of how a stakeholder should reach out, or who the enquiry actually goes to.
What a structured public site changes
Your science presented clearly, stakeholders guided properly, contact kept simple.
We structure company, pipeline, and platform information around content you supply and approve, present investor and partner materials clearly, and keep the contact form to general fields only. We can also help harden the website itself once it's live, which is a separate, narrower service and does not constitute regulatory or scientific validation -- see our website security service.
- Scientific and pipeline content structured clearly, not fact-checked or validated by us
- Company, platform, and program pages organised for a general stakeholder
- Investor and partner materials presented consistently, supplied and approved by you
- A general contact form only, kept away from protected research data
- An honest, explicit statement of what this website is not
What's included
What a biotech public website build actually covers.
Scoped to public-facing information and stakeholder communication -- not clinical or laboratory systems.
Company & platform information architecture
Structure
Pipeline & program pages
Pipeline
Accessibility-conscious design
Accessibility
See our interface design approachInvestor & partner content pages
Stakeholders
General contact path
Contact
Content governance
Governance
Public-site SEO foundations
SEO
See our SEO approachOngoing maintenance
Care plans
Explore maintenanceThe stakeholder's journey
Find company, understand platform, review materials, choose contact path, continue directly.
The site supports this path up to the point of contact -- what happens after that is your own process.
Find company
A stakeholder searches for or is referred to your organisation.
Understand platform
Plain-language company and platform information helps them understand what you do.
Review materials
Pipeline, program, or investor content you supply helps them evaluate further.
Choose contact path
A general enquiry form or contact details, kept simple.
Continue directly
Deeper diligence, data rooms, or regulatory discussions happen through your own process, not the website.
What changes
A generic biotech brochure vs. a structured public information site.
Both aim to inform visitors. The difference is clarity, honest scope, and content that is clearly yours, not ours.
Who this suits
Scoped honestly -- for public information, not every biotech use case.
We're upfront about what fits this service, and what needs a different, specialist scope entirely.
Biotech & life sciences companies
Public site
See our web design approachEarly-stage & pre-clinical organisations
Early stage
Organisations adding a new program
New program
Situations outside this scope
Out of scope
Choose your starting point
Three ways to start, depending on where your organisation's website is today.
A new public site, a redesign, or ongoing content support -- each stays within the honest scope above.
New
New public website
Company overview, pipeline or platform pages, and a general contact path built from content you supply.
- Company & platform information architecture
- Pipeline & program pages
- Accessible, semantic structure
- General contact form only
Recommended
Redesign & content restructure
For an existing site that needs clearer structure and an honestly-scoped presentation.
- Content and structure review
- Plain-language restructuring of supplied content
- Redirect plan to protect existing SEO value
- Investor and partner content presented consistently
Ongoing
Content maintenance
Keep company, pipeline, and program information current as your organisation changes.
- Monthly content updates
- New program or platform pages
- Security and performance upkeep
- See our website maintenance service
What ships with every biotech public website engagement
Company & platform pages
Company and platform information written in plain language for a general stakeholder.
Pipeline & program pages
Pipeline or program information you supply, presented with clear structure.
Accessible structure
Semantic markup, contrast, and keyboard navigation built in as a design practice.
General contact form
A simple enquiry form kept to general fields -- no protected research data requested.
An honest scope statement
A clear note on what this engagement does not include, so expectations match reality.
CMS access
A way to update company and pipeline content yourself, without developer help.
Ready to talk through your public website?
Tell us about your organisation -- we'll tell you honestly what's in scope.
Whether it's a new site or a redesign, you'll get a clear, honest read on scope before anything starts -- no regulatory claim, no clinical system promise, no invented outcome.
FAQs
Biotech website design -- frequently asked questions.
Straight answers on scope, what we don't offer, and what this engagement can and cannot promise.
Need work on the website itself once it's live? See our website security service (standard hardening, not scientific or regulatory validation).
No, and we won't claim that we do -- content accuracy and regulatory compliance remain your responsibility; we structure and present whatever you supply and approve. We are a web design agency, not a scientific reviewer, a regulatory body, or a compliance-certifying service, and have no such practice to offer.
No. Clinical trial management systems, laboratory information systems, and protected research-data infrastructure are regulated, specialist systems -- we haven't published evidence of building any of these, so we won't claim the capability here. What we build is your public-facing website: company overview, pipeline or platform pages, and a way for stakeholders to get in touch.
You are. Scientific findings, study claims, pipeline data, regulatory status, certifications, and investor materials must be supplied and approved by you -- we structure and present that content clearly, but we do not write, verify, or fact-check it on your behalf.
We haven't published Drupal build work, so we won't claim that platform here. Our evidenced stack is Next.js/React with a Laravel CMS, and WordPress where a project calls for it.
We do not claim AWS-specific hosting expertise or audit-log infrastructure as a delivered capability. What we can do is standard website-level hardening -- see our website security service -- which is general hardening, not scientific or regulatory validation, and not a compliance certification of any kind.
We won't promise an investor-acquisition outcome -- that depends on your science, your market, and your existing relationships, not just the website. What we build is a clearly structured site that presents whatever investor-facing content you supply in an organised, professional way.
No biotech- or pharma-specific case study or testimonial exists in our current portfolio, and we won't fabricate one. If you'd like to see examples of our general web design work, we're happy to share what's genuinely available.
Yes. All projects include responsive design and testing across devices, so investors, partners, and other stakeholders can review your site comfortably on any screen.
Locations
Explore Our Locations
We proudly serve clients in major cities worldwide, delivering exceptional web design, development, and digital marketing services.